Bristol-Myers Squibb Company
SUBSTITUTED INDOLE ETHER COMPOUNDS
Last updated:
Abstract:
Disclosed are compounds of Formula (I) (I) N-oxides, or salts thereof, wherein R.sub.1, G, A, R.sub.5, and n are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
14 Dec 2018
Issue date:
11 Mar 2021